What is the best antibiotic for group B streptococcus (GBS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Group B Streptococcus

Penicillin G is the best antibiotic for Group B Streptococcus infections, with a recommended dosing regimen of 5 million units IV initially, followed by 2.5-3.0 million units IV every 4 hours. 1

First-Line Treatment

  • Penicillin G is superior to ampicillin because it has a narrower spectrum of activity, which reduces selection pressure for resistant organisms while maintaining excellent activity against GBS 1, 2
  • The dosing range of 2.5-3.0 million units every 4 hours achieves adequate drug levels in fetal circulation and amniotic fluid while avoiding neurotoxicity 3
  • All GBS isolates worldwide remain 100% susceptible to penicillin, making resistance a non-issue 4
  • Penicillin G is bactericidal during active bacterial multiplication by inhibiting cell wall peptidoglycan synthesis 5

Alternative for Non-Allergic Patients

  • Ampicillin is an acceptable alternative with dosing of 2 g IV initially, then 1 g IV every 4 hours 1
  • However, ampicillin's broader spectrum makes it less preferable than penicillin G when both options are available 1, 2

Treatment Algorithm for Penicillin-Allergic Patients

Step 1: Assess Allergy Severity

  • High-risk for anaphylaxis is defined as: history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration 3, 4
  • Verify the allergy history carefully, as true penicillin allergy occurs in far fewer patients than reported 4

Step 2: Non-Severe Penicillin Allergy

  • Use cefazolin: 2 g IV initially, then 1 g IV every 8 hours 1, 6
  • Cross-reactivity between penicillins and cephalosporins occurs in only approximately 10% of penicillin-allergic patients 4
  • GBS isolates remain highly susceptible to cefazolin with consistently low minimum inhibitory concentrations 6

Step 3: Severe Penicillin Allergy

  • Obtain susceptibility testing for clindamycin and erythromycin immediately 4, 6
  • If susceptible to both clindamycin and erythromycin: Use clindamycin 900 mg IV every 8 hours 1, 6
  • If resistant or susceptibility unknown: Use vancomycin 1 g IV every 12 hours 1, 6
  • Never use cefazolin in severe penicillin allergy due to cross-reactivity risk 4

Critical Considerations

  • Erythromycin is no longer acceptable for GBS treatment due to resistance rates up to 20.2% 3, 1
  • Clindamycin resistance has increased to 3-15% in the US, making susceptibility testing mandatory before use 1
  • Test for inducible clindamycin resistance in isolates susceptible to clindamycin but resistant to erythromycin 1
  • The risk of penicillin-induced anaphylaxis is 4/10,000 to 4/100,000, which is far outweighed by benefits of preventing GBS disease 1

Important Pitfalls to Avoid

  • Only use IV administration - oral or intramuscular routes do not achieve adequate concentrations for GBS treatment 1
  • Vancomycin should be reserved for cases with no other options due to concerns about promoting antimicrobial resistance 6
  • Always obtain susceptibility testing when treating penicillin-allergic patients, as empiric therapy may fail 4, 6
  • Consider infectious disease consultation for complicated cases or limited treatment options 4

References

Guideline

Group B Streptococcus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Group B Strep UTI in Patients with Severe Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternative Antibiotics for Group B Streptococcus (GBS) Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.